null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Breast Cancer (Translational Therapeutic Strategies)

List Price: $189.99
SKU:
9780849374166
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Gary H. Lyman, Harold J. Burstein
    Format:
    Hardcover
    Pages:
    344
    Publisher:
    CRC Press (January 29, 2007)
    Imprint:
    CRC Press
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9780849374166
    Weight:
    28.25oz
    Dimensions:
    6" x 9"
    File:
    TAYLORFRANCIS-TayFran_261003042832725-20261003.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $189.99
    Country of Origin:
    United States
    Pub Discount:
    30
    Series:
    Translational Medicine
    Case Pack:
    24
    As low as:
    $180.49
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
  • Overview

    Considering the impact of translational breakthroughs on the early detection, diagnosis, prevention, and treatment of breast cancer, this all-encompassing guide collects cutting-edge research on the most promising strategies and agents likely to impact the management and long-term outcomes of women with breast cancer. This book will provide current information on rapidly evolving translational therapies, as well as improved strategies for the selection of patients for these treatments.